Gilead Sciences (GILD): FMR LLC now owns 5.3% of GILD as a passive investor 5.3%
FMR LLC now owns 5.3% of GILD as a passive investor.
- 5.3%
- Stake
- 65.5M
- Shares owned
- Stake as of
- Dec 31, 2025
- Filed
- Feb 5, 2026
What stands out in this filing
- Reported stake 5.3% (65,539,476.75 shares).
- A 13G is the short form for a passive owner of more than 5%.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 46 days earlier (Nov 15, 2025). The first one after it: reported its results, 41 days later (Feb 10, 2026).
- Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 17 employees
- Insider · 1 personInsiders: 3 sales (~$6.6M)
- Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 19 , 2025, Gilead Sciences, Inc., a Delaware corporation (the “Company”), announced that Deborah H. Telman will no longer serve as Executive Vice President, Corporate Affairs and General Counsel of the Company as of December 5, 2025.”
- Insider · 2 peopleInsiders: 3 sales (~$3.8M)
- InsiderDirector sold ~$357K of GILD shares in the open market
- Insider · 3 peopleInsiders: 4 sales (~$2.2M)
- Government · Federal Register noticeDetermination That DEMEROL (Meperidine Hydrochloride) Tablet, 100 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Insider · 2 peopleInsiders: 2 sales (~$732K)
- InsiderCEO sold ~$1.25M of GILD shares in the open market
What came next
- Insider · 2 peopleInsiders: 2 sales (~$746K)
- InsiderDirector sold ~$618K of GILD shares in the open market
- Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 34 employees
- InsiderCEO sold ~$15.6M of GILD shares in the open market
- CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
- Insider · 1 personInsiders: 2 sales (~$1.4M)
- 5% stakeFMR LLC reported a passive stake (13G) of 5.3%
- InsiderCEO sold ~$17.3M of GILD shares in the open market
- Company filing · Form 8-K · ResultsReported its results
- Insider · 2 peopleInsiders: 4 sales (~$4.8M)
- Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Insider · 1 personInsiders: 3 sales (~$1.4M)
- Insider · 2 peopleInsiders: 2 sales (~$865K)
- Layoff notice · 333 Lakeside Drive San Mateo CA 94404Layoff notice filed in CA: 51 employees
- 5% stakeThe Vanguard Group reported a passive stake (13G)
- InsiderCEO sold ~$1.37M of GILD shares in the open market
- Insider · 2 peopleInsiders: 2 sales (~$846K)
- Insider · 1 personInsiders: 2 sales (~$1.3M)
- 5% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Layoff notice · 800 Bridge Parkway Redwood City CA 94065Layoff notice filed in CA: 108 employees
How to read SEC Schedule 13G
A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.
Full guide: Schedule 13D vs Schedule 13G: what is the difference?
What else is on file for Gilead Sciences
For Gilead Sciences, OQRO holds 42 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.
How this filing works
Explore the data
Common questions
What does this filing report about Gilead Sciences (GILD) stock?
FMR LLC now owns 5.3% of GILD as a passive investor. Of the company, Schedule 13G (passive).
When did it happen, and when was it made public?
Stake as of: Dec 31, 2025. Filed: Feb 5, 2026.
What stands out in this filing?
Reported stake 5.3% (65,539,476.75 shares). A 13G is the short form for a passive owner of more than 5%.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Schedule 13G, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Gilead Sciences recently?
For Gilead Sciences, OQRO holds 42 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GILD page.
Does this mean GILD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Gilead Sciences
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 16, 2026
Everything OQRO holds on this company is on its GILD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
